Evidence map›Paper›PMID 30461272›Full record

ArticleJournal of the American Chemical Society2018

Total Synthesis, Biological Evaluation, and Target Identification of Rare Abies Sesquiterpenoids.

Dexter C Davis, Dominic G Hoch, Li Wu, Daniel Abegg, Brandon S Martin, Zhong-Yin Zhang, Alexander Adibekian, Mingji Dai

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 46 citations in OpenAlex.

  1. Total Synthesis of (±)-Stemocurtisine via Catalytic Carbonylation.Journal of the American Chemical Society · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Concise Total Syntheses of (Journal of the American Chemical Society · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Total Synthesis and Target Identification of the Curcusone Diterpenes.Journal of the American Chemical Society · 2021
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dexter C DavisDepartment of Chemistry, Center for Cancer Research and Institute for Drug Discovery , Purdue University , West Lafayette , Indiana 47907 , United States.
Dominic G HochDepartment of Chemistry , The Scripps Research Institute , 130 Scripps Way , Jupiter , Florida 33458 , United States.
Li WuDepartment of Medicinal Chemistry and Molecular Pharmacology , Purdue University , West Lafayette , Indiana 47907 , United States.
Daniel AbeggDepartment of Chemistry , The Scripps Research Institute , 130 Scripps Way , Jupiter , Florida 33458 , United States.
Brandon S MartinDepartment of Chemistry, Center for Cancer Research and Institute for Drug Discovery , Purdue University , West Lafayette , Indiana 47907 , United States.
Zhong-Yin ZhangDepartment of Chemistry, Center for Cancer Research and Institute for Drug Discovery , Purdue University , West Lafayette , Indiana 47907 , United States.ORCID 0000-0001-5527-7910
Alexander AdibekianDepartment of Chemistry , The Scripps Research Institute , 130 Scripps Way , Jupiter , Florida 33458 , United States.ORCID 0000-0001-6453-0244
Mingji DaiDepartment of Chemistry, Center for Cancer Research and Institute for Drug Discovery , Purdue University , West Lafayette , Indiana 47907 , United States.ORCID 0000-0001-7956-6426
Purdue University West Lafayette · USScripps Research Institute · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI ANDREW D MESECAR · 1985 to 2026
$43.4M
Development of SHP2 inhibitors for targeted anti-cancer therapyR01CA207288 · NCI · PURDUE UNIVERSITY · PI ZHANG, ZHONG-YIN · 2017 to 2021
$2.3M
NCI NIH HHS P30 CA023168NCI NIH HHS R01 CA207288
6 · The paper itself

Abstract

Abiespiroside A (1), beshanzuenone C (2), and beshanzuenone D (3) belong to the Abies sesquiterpenoid family. Beshanzuenones C (2) and D (3) are isolated from the critically endangered Chinese fir tree species Abies beshanzuensis and demonstrated weak inhibiting activity against protein tyrosine phosphatase 1B (PTP1B). We describe herein the first total syntheses of these Abies sesquiterpenoids relying on the sustainable and inexpensive chiral pool molecule (+)-carvone. The syntheses feature a palladium-catalyzed hydrocarbonylative lactonization to install the 6,6-fused bicyclic ring system and a Dreiding-Schmidt reaction to build the oxaspirolactone moiety of these target molecules. Our chemical total syntheses of these Abies sesquiterpenoids have enabled (i) the validation of beshanzuenone C's weak PTP1B inhibiting potency, (ii) identification of new synthetic analogs with promising and selective protein tyrosine phosphatase SHP2 inhibiting potency, and (iii) preparation of azide-tagged probe molecules for target identification via a chemoproteomic approach. The latter has resulted in the identification and evaluation of DNA polymerase epsilon subunit 3 (POLE3) as one of the novel cellular targets of these Abies sesquiterpenoids and their analogs. More importantly, via POLE3 inactivation by probe molecule 29 and knockdown experiment, we further demonstrated that targeting POLE3 with small molecules may be a novel strategy for chemosensitization to DNA damaging drugs such as etoposide in cancer.

Indexed as

AbiesAntineoplastic AgentsCell Line, TumorCyclizationDNA-Binding ProteinsDNA Polymerase IIIDrug SynergismEnzyme InhibitorsEtoposideHumansNucleoproteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11SesquiterpenesAntineoplastic AgentsDNA-Binding ProteinsDNA Polymerase IIIEnzyme InhibitorsEtoposideNucleoproteinsPOLE3 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11Sesquiterpenes

Identifiers

PMID30461272
PMCPMC6470006
OpenAlexW2901637069

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.